Ashfield Healthcare Communications Expands Footprint with Argon Global Healthcare Network Alliance
The UK’s Ashfield Healthcare Communications and Argon Global Healthcare Network have announced that they have combined their capabilities to assist clients with managing their brands in existing locations and expanding into new.
“The complementary service offerings and greater geographical reach from Ashfield and Argon will provide clients a non-holding company approach to the global environment. Collectively this partnership provides our clients with unprecedented agility and access to a full breadth of communications services tailored with a deep understanding of cultural and business nuances for their regional and local needs,” a press release reports.
Ashfield Healthcare Communications president Doug Burcin commented: “I am delighted with this partnership in that it continues to deliver on our approach to being a truly global micro network. We have a well-established presence in the UK, Germany, Japan and US for delivering our solutions at the intersection of science, data and creativity so we are excited to come together with the Argon Global Healthcare Network to be able to deliver this on an even more global scale.”
Doug Burcin
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Pfizer, GSK Gain ACIP Recommendations for RSV and Meningococcal Vaccines
April 18th 2025The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand access to Pfizer’s respiratory syncytial virus vaccine Abrysvo for high-risk adults in their 50s and voted in favor of GSK’s meningococcal vaccine, Penmenvy, for streamlined adolescent protection.
